Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities.

Morgan EA, Sweeney MP, Tomoka T, Kopp N, Gusenleitner D, Redd RA, Carey CD, Masamba L, Kamiza S, Pinkus GS, Neuberg DS, Rodig SJ, Milner DA Jr, Weinstock DM.

Blood Adv. 2016 Nov 22;1(1):84-92. doi: 10.1182/bloodadvances.2016000026. eCollection 2016 Nov 29.

2.

HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma.

Jacobson C, Kopp N, Layer JV, Redd RA, Tschuri S, Haebe S, van Bodegom D, Bird L, Christie AL, Christodoulou A, Saur A, Tivey T, Zapf S, Bararia D, Zimber-Strobl U, Rodig SJ, Weigert O, Weinstock DM.

Blood. 2016 Nov 24;128(21):2517-2526. Epub 2016 Oct 14.

3.

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Townsend EC, Murakami MA, Christodoulou A, Christie AL, Köster J, DeSouza TA, Morgan EA, Kallgren SP, Liu H, Wu SC, Plana O, Montero J, Stevenson KE, Rao P, Vadhi R, Andreeff M, Armand P, Ballen KK, Barzaghi-Rinaudo P, Cahill S, Clark RA, Cooke VG, Davids MS, DeAngelo DJ, Dorfman DM, Eaton H, Ebert BL, Etchin J, Firestone B, Fisher DC, Freedman AS, Galinsky IA, Gao H, Garcia JS, Garnache-Ottou F, Graubert TA, Gutierrez A, Halilovic E, Harris MH, Herbert ZT, Horwitz SM, Inghirami G, Intlekofer AM, Ito M, Izraeli S, Jacobsen ED, Jacobson CA, Jeay S, Jeremias I, Kelliher MA, Koch R, Konopleva M, Kopp N, Kornblau SM, Kung AL, Kupper TS, LeBoeuf NR, LaCasce AS, Lees E, Li LS, Look AT, Murakami M, Muschen M, Neuberg D, Ng SY, Odejide OO, Orkin SH, Paquette RR, Place AE, Roderick JE, Ryan JA, Sallan SE, Shoji B, Silverman LB, Soiffer RJ, Steensma DP, Stegmaier K, Stone RM, Tamburini J, Thorner AR, van Hummelen P, Wadleigh M, Wiesmann M, Weng AP, Wuerthner JU, Williams DA, Wollison BM, Lane AA, Letai A, Bertagnolli MM, Ritz J, Brown M, Long H, Aster JC, Shipp MA, Griffin JD, Weinstock DM.

Cancer Cell. 2016 Jul 11;30(1):183. doi: 10.1016/j.ccell.2016.06.008. Epub 2016 Jul 11. No abstract available.

4.

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.

Melchardt T, Hufnagl C, Weinstock DM, Kopp N, Neureiter D, Tränkenschuh W, Hackl H, Weiss L, Rinnerthaler G, Hartmann TN, Greil R, Weigert O, Egle A.

Oncotarget. 2016 Aug 9;7(32):51494-51502. doi: 10.18632/oncotarget.9860.

5.

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Townsend EC, Murakami MA, Christodoulou A, Christie AL, Köster J, DeSouza TA, Morgan EA, Kallgren SP, Liu H, Wu SC, Plana O, Montero J, Stevenson KE, Rao P, Vadhi R, Andreeff M, Armand P, Ballen KK, Barzaghi-Rinaudo P, Cahill S, Clark RA, Cooke VG, Davids MS, DeAngelo DJ, Dorfman DM, Eaton H, Ebert BL, Etchin J, Firestone B, Fisher DC, Freedman AS, Galinsky IA, Gao H, Garcia JS, Garnache-Ottou F, Graubert TA, Gutierrez A, Halilovic E, Harris MH, Herbert ZT, Horwitz SM, Inghirami G, Intlekofer AM, Ito M, Izraeli S, Jacobsen ED, Jacobson CA, Jeay S, Jeremias I, Kelliher MA, Koch R, Konopleva M, Kopp N, Kornblau SM, Kung AL, Kupper TS, LeBoeuf NR, LaCasce AS, Lees E, Li LS, Look AT, Murakami M, Muschen M, Neuberg D, Ng SY, Odejide OO, Orkin SH, Paquette RR, Place AE, Roderick JE, Ryan JA, Sallan SE, Shoji B, Silverman LB, Soiffer RJ, Steensma DP, Stegmaier K, Stone RM, Tamburini J, Thorner AR, van Hummelen P, Wadleigh M, Wiesmann M, Weng AP, Wuerthner JU, Williams DA, Wollison BM, Lane AA, Letai A, Bertagnolli MM, Ritz J, Brown M, Long H, Aster JC, Shipp MA, Griffin JD, Weinstock DM.

Cancer Cell. 2016 Apr 11;29(4):574-586. doi: 10.1016/j.ccell.2016.03.008. Erratum in: Cancer Cell. 2016 Jul 11;30(1):183.

6.

The anatomical distribution of genetic associations.

Wells A, Kopp N, Xu X, O'Brien DR, Yang W, Nehorai A, Adair-Kirk TL, Kopan R, Dougherty JD.

Nucleic Acids Res. 2015 Dec 15;43(22):10804-20. doi: 10.1093/nar/gkv1262. Epub 2015 Nov 19.

7.

Moving from capstones toward cornerstones: successes and challenges in applying systems biology to identify mechanisms of autism spectrum disorders.

Kopp N, Climer S, Dougherty JD.

Front Genet. 2015 Oct 7;6:301. doi: 10.3389/fgene.2015.00301. eCollection 2015. Review.

8.

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.

Pastore A, Jurinovic V, Kridel R, Hoster E, Staiger AM, Szczepanowski M, Pott C, Kopp N, Murakami M, Horn H, Leich E, Moccia AA, Mottok A, Sunkavalli A, Van Hummelen P, Ducar M, Ennishi D, Shulha HP, Hother C, Connors JM, Sehn LH, Dreyling M, Neuberg D, Möller P, Feller AC, Hansmann ML, Stein H, Rosenwald A, Ott G, Klapper W, Unterhalt M, Hiddemann W, Gascoyne RD, Weinstock DM, Weigert O.

Lancet Oncol. 2015 Sep;16(9):1111-1122. doi: 10.1016/S1470-2045(15)00169-2. Epub 2015 Aug 6.

PMID:
26256760
9.

Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia.

Wu SC, Li LS, Kopp N, Montero J, Chapuy B, Yoda A, Christie AL, Liu H, Christodoulou A, van Bodegom D, van der Zwet J, Layer JV, Tivey T, Lane AA, Ryan JA, Ng SY, DeAngelo DJ, Stone RM, Steensma D, Wadleigh M, Harris M, Mandon E, Ebel N, Andraos R, Romanet V, Dölemeyer A, Sterker D, Zender M, Rodig SJ, Murakami M, Hofmann F, Kuo F, Eck MJ, Silverman LB, Sallan SE, Letai A, Baffert F, Vangrevelinghe E, Radimerski T, Gaul C, Weinstock DM.

Cancer Cell. 2015 Jul 13;28(1):29-41. doi: 10.1016/j.ccell.2015.06.005.

10.

Mutations in G protein β subunits promote transformation and kinase inhibitor resistance.

Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y, Weigert O, Kopp N, Wu SC, Kim SS, Liu H, Tivey T, Christie AL, Elpek KG, Card J, Gritsman K, Gotlib J, Deininger MW, Makishima H, Turley SJ, Javidi-Sharifi N, Maciejewski JP, Jaiswal S, Ebert BL, Rodig SJ, Tyner JW, Marto JA, Weinstock DM, Lane AA.

Nat Med. 2015 Jan;21(1):71-5. doi: 10.1038/nm.3751. Epub 2014 Dec 8.

11.

Developmental dynamics of neurotensin binding sites in the human hypothalamus during the first postnatal year.

Najimi M, Sarrieau A, Kopp N, Chigr F.

Front Cell Neurosci. 2014 Sep 10;8:251. doi: 10.3389/fncel.2014.00251. eCollection 2014.

12.

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.

Odejide O, Weigert O, Lane AA, Toscano D, Lunning MA, Kopp N, Kim S, van Bodegom D, Bolla S, Schatz JH, Teruya-Feldstein J, Hochberg E, Louissaint A, Dorfman D, Stevenson K, Rodig SJ, Piccaluga PP, Jacobsen E, Pileri SA, Harris NL, Ferrero S, Inghirami G, Horwitz SM, Weinstock DM.

Blood. 2014 Feb 27;123(9):1293-6. doi: 10.1182/blood-2013-10-531509. Epub 2013 Dec 17.

13.

An autoradiographic study of neurotensin receptors in the human hypothalamus.

Najimi M, Sarrieau A, Kopp N, Chigr F.

Acta Histochem. 2014 Mar;116(2):382-9. doi: 10.1016/j.acthis.2013.09.008. Epub 2013 Oct 18.

PMID:
24144485
14.

Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia.

Lane AA, Odejide O, Kopp N, Kim S, Yoda A, Erlich R, Wagle N, Abel GA, Rodig SJ, Antin JH, Weinstock DM.

Leukemia. 2013 Apr;27(4):968-71. doi: 10.1038/leu.2013.30. Epub 2013 Feb 1. No abstract available.

15.

Next-generation cDNA screening for oncogene and resistance phenotypes.

Shindoh N, Yoda A, Yoda Y, Sullivan TJ, Weigert O, Lane AA, Kopp N, Bird L, Rodig SJ, Fox EA, Weinstock DM.

PLoS One. 2012;7(11):e49201. doi: 10.1371/journal.pone.0049201. Epub 2012 Nov 7.

16.

Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2.

van Bodegom D, Zhong J, Kopp N, Dutta C, Kim MS, Bird L, Weigert O, Tyner J, Pandey A, Yoda A, Weinstock DM.

Blood. 2012 Oct 4;120(14):2853-63. doi: 10.1182/blood-2012-02-413252. Epub 2012 Aug 20.

17.

BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.

Ott CJ, Kopp N, Bird L, Paranal RM, Qi J, Bowman T, Rodig SJ, Kung AL, Bradner JE, Weinstock DM.

Blood. 2012 Oct 4;120(14):2843-52. doi: 10.1182/blood-2012-02-413021. Epub 2012 Aug 17.

18.

BCL2 suppresses PARP1 function and nonapoptotic cell death.

Dutta C, Day T, Kopp N, van Bodegom D, Davids MS, Ryan J, Bird L, Kommajosyula N, Weigert O, Yoda A, Fung H, Brown JR, Shapiro GI, Letai A, Weinstock DM.

Cancer Res. 2012 Aug 15;72(16):4193-203. doi: 10.1158/0008-5472.CAN-11-4204. Epub 2012 Jun 11.

19.

Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation.

Weigert O, Kopp N, Lane AA, Yoda A, Dahlberg SE, Neuberg D, Bahar AY, Chapuy B, Kutok JL, Longtine JA, Kuo FC, Haley T, Salois M, Sullivan TJ, Fisher DC, Fox EA, Rodig SJ, Antin JH, Weinstock DM.

Cancer Discov. 2012 Jan;2(1):47-55. doi: 10.1158/2159-8290.CD-11-0208. Epub 2011 Dec 12.

20.

Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition.

Weigert O, Lane AA, Bird L, Kopp N, Chapuy B, van Bodegom D, Toms AV, Marubayashi S, Christie AL, McKeown M, Paranal RM, Bradner JE, Yoda A, Gaul C, Vangrevelinghe E, Romanet V, Murakami M, Tiedt R, Ebel N, Evrot E, De Pover A, Régnier CH, Erdmann D, Hofmann F, Eck MJ, Sallan SE, Levine RL, Kung AL, Baffert F, Radimerski T, Weinstock DM.

J Exp Med. 2012 Feb 13;209(2):259-73. doi: 10.1084/jem.20111694. Epub 2012 Jan 23.

21.

Ultrastructural characteristics (or evaluation) of Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies or prion diseases.

Liberski PP, Sikorska B, Hauw JJ, Kopp N, Streichenberger N, Giraud P, Boellaard J, Budka H, Kovacs GG, Ironside J, Brown P.

Ultrastruct Pathol. 2010 Dec;34(6):351-61. doi: 10.3109/01913123.2010.491175.

PMID:
21070167
22.

Identification of a synthetic peptide inducing cross-reactive antibodies binding to Rhipicephalus (Boophilus) decoloratus, Rhipicephalus (Boophilus) microplus, Hyalomma anatolicum anatolicum and Rhipicephalus appendiculatus BM86 homologues.

Kopp N, Diaz D, Amacker M, Odongo DO, Beier K, Nitsch C, Bishop RP, Daubenberger CA.

Vaccine. 2009 Dec 10;28(1):261-9. doi: 10.1016/j.vaccine.2009.09.085. Epub 2009 Oct 4.

PMID:
19808026
23.

Tubulovesicular structures are a consistent (and unexplained) finding in the brains of humans with prion diseases.

Liberski PP, Sikorska B, Hauw JJ, Kopp N, Streichenberger N, Giraud P, Budka H, Boellaard JW, Brown P.

Virus Res. 2008 Mar;132(1-2):226-8. doi: 10.1016/j.virusres.2007.11.008. Epub 2008 Jan 14.

PMID:
18164506
24.

Localized quorum sensing in Vibrio fischeri.

Parent ME, Snyder CE, Kopp ND, Velegol D.

Colloids Surf B Biointerfaces. 2008 Apr 1;62(2):180-7. Epub 2007 Oct 2.

PMID:
18006285
25.

Chemotaxis of nonbiological colloidal rods.

Hong Y, Blackman NM, Kopp ND, Sen A, Velegol D.

Phys Rev Lett. 2007 Oct 26;99(17):178103. Epub 2007 Oct 26.

PMID:
17995374
26.

IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program.

Argaw AT, Zhang Y, Snyder BJ, Zhao ML, Kopp N, Lee SC, Raine CS, Brosnan CF, John GR.

J Immunol. 2006 Oct 15;177(8):5574-84.

27.

Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium.

Alafuzoff I, Pikkarainen M, Al-Sarraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Hauw JJ, Kamphorst W, King A, Kopp N, Korkolopoulou P, Kovács GG, Meyronet D, Parchi P, Patsouris E, Preusser M, Ravid R, Roggendorf W, Seilhean D, Streichenberger N, Thal DR, Kretzschmar H.

J Neuropathol Exp Neurol. 2006 Aug;65(8):740-57.

PMID:
16896308
28.

[11C]-Methionine PET: dysembryoplastic neuroepithelial tumours compared with other epileptogenic brain neoplasms.

Rosenberg DS, Demarquay G, Jouvet A, Le Bars D, Streichenberger N, Sindou M, Kopp N, Mauguière F, Ryvlin P.

J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1686-92.

29.

A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy.

Ros R, Thobois S, Streichenberger N, Kopp N, Sánchez MP, Pérez M, Hoenicka J, Avila J, Honnorat J, de Yébenes JG.

Arch Neurol. 2005 Sep;62(9):1444-50.

PMID:
16157753
30.

[Heidenhain's variant of Creutzfeldt-Jakob's disease].

Fauquembergue M, Tilikete C, Perret-Liaudet A, Kopp N, Krolak-Salmon P, Vighetto A.

Rev Neurol (Paris). 2005 May;161(5):578-81. French.

PMID:
16106810
31.

Spinocerebellar ataxia with sensory neuropathy (SCA25).

Stevanin G, Broussolle E, Streichenberger N, Kopp N, Brice A, Durr A.

Cerebellum. 2005;4(1):58-61.

PMID:
15895562
32.

Ultrastructural pathology of prion diseases revisited: brain biopsy studies.

Liberski PP, Streichenberger N, Giraud P, Soutrenon M, Meyronnet D, Sikorska B, Kopp N.

Neuropathol Appl Neurobiol. 2005 Feb;31(1):88-96.

PMID:
15634235
33.

Autophagy is a part of ultrastructural synaptic pathology in Creutzfeldt-Jakob disease: a brain biopsy study.

Sikorska B, Liberski PP, Giraud P, Kopp N, Brown P.

Int J Biochem Cell Biol. 2004 Dec;36(12):2563-73.

PMID:
15325593
34.

Quantitative study of spongiform change in putamen of 24 cases of Creutzfeldt-Jakob disease.

Truchot L, Bencsik A, Perret-Liaudet A, Biacabe AG, Richard M, Ironside J, Kopp N, Streichenberger N.

J Neuropathol Exp Neurol. 2004 Mar;63(3):193-8.

PMID:
15055443
35.

Prion protein accumulation involving the peripheral nervous system in a sporadic case of Creutzfeldt-Jakob disease.

Favereaux A, Quadrio I, Perret-Liaudet A, Vital C, Ouallet JC, Brochet B, Biacabe AG, Petry KG, Kopp N, Vital A.

Neuropathol Appl Neurobiol. 2003 Dec;29(6):602-5. No abstract available.

PMID:
14636167
36.

Quinacrine-induced cytolytic hepatitis in sporadic Creutzfeldt-Jakob disease.

Scoazec JY, Krolak-Salmon P, Casez O, Besson G, Thobois S, Kopp N, Perret-Liaudet A, Streichenberger N.

Ann Neurol. 2003 Apr;53(4):546-7. No abstract available.

PMID:
12666126
37.

Dumbbell-shaped epidural capillary hemangioma.

Badinand B, Morel C, Kopp N, Tran Min VA, Cotton F.

AJNR Am J Neuroradiol. 2003 Feb;24(2):190-2.

38.

Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies.

Richard M, Biacabe AG, Streichenberger N, Ironside JW, Mohr M, Kopp N, Perret-Liaudet A.

Acta Neuropathol. 2003 Mar;105(3):296-302. Epub 2002 Nov 22.

PMID:
12557018
39.

Chordoid glioma of the third ventricle: a report of two new cases, with further evidence supporting an ependymal differentiation, and review of the literature.

Pasquier B, Péoc'h M, Morrison AL, Gay E, Pasquier D, Grand S, Sindou M, Kopp N.

Am J Surg Pathol. 2002 Oct;26(10):1330-42. Review.

PMID:
12360048
40.

[Hashimoto's encephalopathy: an anatomicoclinical observation].

Perrot X, Giraud P, Biacabe AG, Perret-Liaudet A, Borson-Chazot F, Gray F, Kopp N, Boulliat J.

Rev Neurol (Paris). 2002 Apr;158(4):461-6. French.

PMID:
11984489
41.

Orofacial dyskinesias in a patient with primary biliary cirrhosis: a clinicopathological case report and review.

Thobois S, Giraud P, Debat P, Gouttard M, Maurizi A, Perret-Liaudet A, Kopp N, Broussolle E.

Mov Disord. 2002 Mar;17(2):415-9.

PMID:
11921137
42.

This is really a case of new variant Creutzfeldt-Jakob. Response to C.J.G. Lang et al. concerning our article Acta Neuropathol (2000) 99:704-708.

Streichenberger N, Biacabe AG, Perret-Liaudet A, Deslys JP, Laplanche JL, Chazot G, Kopp N.

Acta Neuropathol. 2001 Dec;102(6):647-8. No abstract available.

PMID:
11761727
43.

Ultrastructural pathology of Creutzfeldt-Jakob disease and fatal familial insomnia.

Liberski PP, Giraud P, Kopp N.

Folia Neuropathol. 2000;38(4):171-3.

PMID:
11693721
44.

Variant Creutzfeldt-Jakob disease is not associated with individual abilities to metabolise organophosphates.

Garofalo O, McFarlane EH, Iyegbe C, Whatley SA, Campbell IC, Kopp N, Will RG.

J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):558-9. No abstract available.

45.

Polyglucosan bodies and temporal lobe epilepsy: an incidental finding or more?

Streichenberger N, Ryvlin P, Guénot M, Sindou M, Kopp N, Mauguière F.

Clin Neuropathol. 2001 Jul-Aug;20(4):172-5.

PMID:
11495006
46.
47.

Regional distribution of benzodiazepine binding sites in the human newborn and infant hypothalamus. A quantitative autoradiographic study.

Najimi M, Bennis M, Moyse E, Miachon S, Kopp N, Chigr F.

Brain Res. 2001 Mar 23;895(1-2):129-38.

PMID:
11259769
48.

Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-- Jakob disease: implications for human health.

Lasmézas CI, Fournier JG, Nouvel V, Boe H, Marcé D, Lamoury F, Kopp N, Hauw JJ, Ironside J, Bruce M, Dormont D, Deslys JP.

Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4142-7. Epub 2001 Mar 20.

49.

Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy.

Antoine JC, Honnorat J, Camdessanché JP, Magistris M, Absi L, Mosnier JF, Petiot P, Kopp N, Michel D.

Ann Neurol. 2001 Feb;49(2):214-21.

PMID:
11220741
50.

Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease.

Haïk S, Brandel JP, Sazdovitch V, Delasnerie-Lauprêtre N, Peoc'h K, Laplanche JL, Privat N, Duyckaerts C, Kemeny JL, Kopp N, Laquerrière A, Mohr M, Deslys JP, Dormont D, Hauw JJ.

Neurology. 2000 Nov 14;55(9):1401-4.

PMID:
11087793

Supplemental Content

Support Center